Recently, a well-known international pharmaceutical company announced that it has officially introduced Jingzhun Jianyuan's biological sample authentication solution and established an efficient internal biological sample detection mechanism. This measure not only greatly improves the quality of its biological sample library, but also provides a solid foundation for drug research and development, accelerating the development process of new drugs.

In recent years, biological sample authentication technology has played an important role in promoting scientific innovation, facilitating precision medicine, and ensuring public health. With the increasing attention of governments around the world to the development of biological sample banks, a series of encouraging and guiding policies have been introduced, creating a favorable environment for the healthy development of biological sample banks.

Biometric authentication technology, as an advanced means of identity recognition, is gradually replacing traditional identity authentication methods. Compared to traditional identity recognition technology, biometric authentication technology has the advantages of being difficult to forget, difficult to replicate, and does not require setting and memorizing numerous passwords, effectively reducing the risk of password loss and leakage.

Biological sample authentication technology plays a crucial role in public health and the development of the bioeconomy. With the continuous development and improvement of biological sample banks, they have played an increasingly important role in promoting scientific innovation, facilitating precision medicine, and ensuring public health.